Stockscreener 앱 받기
1.98
1.00%
-0.02
시장 영업 전:
1.98
Prokidney Corp 주식(PROK)의 최신 뉴스
Is ProKidney Corp. stock a top performer YTDInflation Watch & Free Reliable Trade Execution Plans - mfd.ru
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - 富途牛牛
Revenue Check: Will ProKidney Corp benefit from geopolitical trendsBreakout Watch & Weekly High Return Forecasts - baoquankhu1.vn
Will ProKidney Corp. stock keep outperforming rivalsJuly 2025 Price Swings & Fast Moving Market Watchlists - mfd.ru
Layoff Watch: Does ProKidney Corp offer margin of safety2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
ProKidney Corp Explodes Into the Spotlight: Breakthrough Stock or Overhyped Trap? - AD HOC NEWS
HC Wainwright Forecasts ProKidney FY2030 Earnings - MarketBeat
Growth Value: Will CVCO benefit from sector rotationJuly 2025 WrapUp & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Is ProKidney Corp stock undervalued right nowMarket Growth Review & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
ProKidney Shares Soar After Citi Lifts Price Target to $9 - MSN
ProKidney: Preserved Long-Term Opportunity but Heightened Timeline Risk Supports Continued Hold Rating - TipRanks
ProKidney Expands Phase 3 REGEN-006 Trial Enrollment Plans - TipRanks
ProKidney CorpTopline data readout of surrogate endpoint expected Q2 2027 - marketscreener.com
Prokidney CorpTopline Data Readout Of Surrogate Endpoint Expected Q2 2027 - TradingView
ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK) - Seeking Alpha
ProKidney Corp. (NASDAQ:PROK) Receives Average Rating of "Hold" from Analysts - MarketBeat
Can ProKidney Corp. continue delivering strong returns2025 Biggest Moves & Daily Profit Maximizing Tips - mfd.ru
Macro Review: Can CBTJ expand its profit margins2025 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn
Aug Action: Can ProKidney Corp be the next market leaderTreasury Yields & Stock Portfolio Risk Management - baoquankhu1.vn
Why is ProKidney Corp. stock going downWeekly Trade Report & Fast Gain Stock Tips - mfd.ru
Ideas Watch: Should I buy ProKidney Corp stock nowTrade Performance Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Profit Review: Does ProKidney Corp outperform in volatile marketsTrade Entry Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Investment Review: Does ProKidney Corp offer margin of safety2025 Support & Resistance & Risk Controlled Daily Trade Plans - baoquankhu1.vn
PROKProKidney Latest Stock News & Market Updates - Stock Titan
ProKidney (NASDAQ:PROK) Stock Price Down 5.5%What's Next? - MarketBeat
Risk Recap: Why is ProKidney Corp stock going downPortfolio Update Report & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Bear Alert: Why is ProKidney Corp stock going downCPI Data & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
H.C. Wainwright Maintains ProKidney(PROK.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
PROK: Pivotal phase III trial of rilparencel for advanced CKD targets Q2 2027 readout, with strong phase II results - TradingView
Recap Report: What is the cash position of ProKidney CorpBuy Signal & Free High Return Stock Watch Alerts - baoquankhu1.vn
ProKidney Advances Rilparencel Program and Manufacturing Expansion - TipRanks
ProKidney Corp Updates on Rilparencel and Phase 3 Trials - TradingView
Will ProKidney Corp. stock maintain momentum in 2025Bull Run & Consistent Return Investment Signals - ulpravda.ru
Why ProKidney Corp. stock could benefit from AI revolutionJuly 2025 Outlook & Risk Managed Investment Strategies - Улправда
Earnings Update: How interest rate cuts could boost ProKidney Corp. stockJuly 2025 Levels & Community Driven Trade Alerts - Улправда
Is ProKidney Corp. stock attractive for passive investorsMarket Movement Recap & Reliable Intraday Trade Alerts - Улправда
Retail Trends: Why ProKidney Corp. stock could benefit from AI revolutionPortfolio Gains Summary & Fast Gain Stock Tips - Улправда
Is ProKidney Corp. stock supported by strong fundamentalsEarnings Growth Summary & Weekly Market Pulse Alerts - Улправда
3 Penny Stocks With Market Caps Under $700M - simplywall.st
Is ProKidney Corp. stock a buy on dipsDouble Top/Bottom Patterns & Rapid Profit Growth - ulpravda.ru
ProKidney (NASDAQ:PROK) Trading 6.9% HigherTime to Buy? - MarketBeat
ProKidney Corp. CEO Bruce Culleton to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
ProKidney Corp. (NASDAQ:PROK) Given Consensus Rating of "Hold" by Analysts - MarketBeat
ProKidney Shares Dip Following FDA Agreement on Rilparencel Approval Strategy - MSN
PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
ProKidney (NASDAQ:PROK) Shares Down 7.3%Should You Sell? - MarketBeat
B of A Securities Downgrades ProKidney (PROK) - MSN
PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - MSN
ProKidney Corp. (PROK) positioned to redefine chronic kidney disease treatment, believes HC Wainwright - MSN
ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright - Yahoo Finance
ProKidney (PROK) price target increased by 15.10% to 6.85 - MSN
ProKidney (PROK) Price Target Increased by 15.10% to 6.85 - Nasdaq
Is ProKidney Corp. stock attractive for growth ETFsWeekly Trade Recap & Weekly High Momentum Picks - Улправда
1.24%
0.19%
자본화:
|
볼륨(24시간):